Search Within

Ellen Marlese Basu

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (12)
Groups
  1. Neuroblastoma Service (25)
  2. Pediatrics, Department of (25)
  3. Sloan Kettering Institute Postdocs (25)
  4. GSK Faculty (20)
  5. Epidemiology and Biostatistics (19)
  6. Tow Center for Developmental Oncology (TCDO) (19)

More Groups

People
  1. Shakeel Modak (23)
  2. Brian Kushner (19)
  3. Stephen Roberts (19)
  4. Nai-Kong Cheung (17)
  5. Audrey Mauguen (16)
  6. Neeta Pandit-Taskar (8)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Pediatric Blood and Cancer (7)
  2. Journal of Clinical Oncology (4)
  3. Cancer Research (2)
  4. Journal of Pediatric Surgery (2)
  5. Cell (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (7)
  2. American Society of Clinical Oncology (4)
  3. American Association for Cancer Research (3)
  4. W.B. Saunders Co-Elsevier Inc. (2)
  5. American Medical Association (1)
  6. Cell Press (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Meeting Abstract

    Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Gundem, G.; Papaemmanuil, E.; Roberts, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Journal Article

    Shahid, S.; Kushner, B. H.; Modak, S.; Basu, E. M.; Rubin, E. M.; Gundem, G.; Papaemmanuil, E.; Roberts, S. S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Extracellular vesicle and particle biomarkers define multiple human cancers
    Journal Article

    Hoshino, A.; Kim, H. S.; Bojmar, L.; Gyan, K. E.; Cioffi, M.; Hernandez, J.; Zambirinis, C. P.; Rodrigues, G.; Molina, H.; Heissel, S.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save